After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Recently, Yahoo Finance discussed the stock, revealing that Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
ATXI belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Avenue Therapeutics Inc is $6.59M. A total of 0.62 million shares were traded on the day, compared to an average of 2.36M shares.
In the most recent transaction, Davidow Robert L sold 353,000 shares of ATXI for 0.14 per share on Dec 11 ’23. After the transaction, the 10% Owner now owns 22,000 company shares. In a previous transaction on Dec 11 ’23, Davidow Robert L sold 264,000 shares at 0.14 per share. ATXI shares that 10% Owner owns now total 681,000.
Among the insiders who bought shares, Fortress Biotech, Inc. acquired of 418,410 shares on Sep 08 ’23 at a per-share price of $0.72. This resulted in the 10% Owner holding 1,032,390 shares of ATXI after the transaction. In another insider transaction, ROSENWALD LINDSAY A MD bought 348,675 shares at $0.72 per share on Sep 08 ’23. Company shares held by the Director now total 354,318.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ATXI has a high of $1.36 and a low of $0.11.
As of this writing, ATXI has an earnings estimate of -$0.12 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of -$0.12 per share and a lower estimate of -$0.12. The company reported an EPS of $0.06 in the last quarter, which was 123.10% higher than expectations of -$0.26.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ATXI’s latest balance sheet shows that the firm has $3.76M in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was $0.06, while its Total Shareholder’s Equity was $3.45M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ATXI is Buy with a score of 5.00.
